Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.

Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.

Matrix metalloproteinase (MMP)-13 is one of the mammalian collagenases that play key roles in tissue remodelling and repair and in progression of diseases such as cancer, arthritis, atherosclerosis, and aneurysm. For collagenase to cleave triple helical collagens, the triple helical structure has to...

Descripció completa

Dades bibliogràfiques
Autors principals:	Stura, E, Visse, R, Cuniasse, P, Dive, V, Nagase, H
Format:	Journal article
Idioma:	English
Publicat:	2013

Ítems similars

Triple-helical collagen unwinding relies on cooperative binding of the catalytic and hemopexin domains of collagenase
per: Manka, S, et al.
Publicat: (2010)

Collagenases and aggrecanases: understanding the role of non-catalytic domains in cartilage matrix breakdown
per: Nagase, H, et al.
Publicat: (2005)

Elucidating the function of non catalytic domains of collagenases and aggrecanases.
per: Nagase, H, et al.
Publicat: (2008)

Elucidating the function of non catalytic domains of collagenases and aggrecanases
per: Nagase, H, et al.
Publicat: (2008)

Kinetic characterization of new selective collagenase 3 (MMP-13) inhibitors as potential therapeutic agents in osteoarthritis
per: Santamaria, S, et al.
Publicat: (2009)

Defining requirements for collagenase cleavage in collagen type III using a bacterial collagen system.
per: Yu, Z, et al.
Publicat: (2012)

An improved collagen zymography approach for evaluating the collagenases MMP-1, MMP-8, and MMP-13
per: Seniz Inanc, et al.
Publicat: (2017-10-01)

Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.
per: Chung, L, et al.
Publicat: (2004)

Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
per: Jyotica Batra, et al.
Publicat: (2013-01-01)

Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.
per: Troeberg, L, et al.
Publicat: (2008)

Inhibitors of human collagenase, MMP1
per: Sergio Roberto de Andrade Leite
Publicat: (2018-04-01)

Targeting exosites on blood coagulation proteases
per: Robson Q. Monteiro
Publicat: (2005-06-01)

Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP.
per: Itoh, Y, et al.
Publicat: (2006)

Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness?
per: Shamaa Ali A, et al.
Publicat: (2008-06-01)

Crystal structure of an active form of human MMP-1.
per: Iyer, S, et al.
Publicat: (2006)

Crystal structure of MT1-MMP hemopexin domain: identification of the dimer interface
per: Tochowicz, A, et al.
Publicat: (2010)

Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide
per: Salvatore Santamaria, et al.
Publicat: (2021-01-01)

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function.
per: Calvin H Yeh, et al.
Publicat: (2016-01-01)

Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands
per: Edmond M. Linossi, et al.
Publicat: (2021-12-01)

Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo
per: Botkjaer, KA, et al.
Publicat: (2016)

Catalytic properties of ADAM12 and its domain deletion mutants.
per: Jacobsen, J, et al.
Publicat: (2008)

Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases.
per: Han, S, et al.
Publicat: (2010)

Inhibition of Neutrophil Collagenase/MMP-8 and Gelatinase B/MMP-9 and Protection against Endotoxin Shock
per: Zheng Qiu, et al.
Publicat: (2014-01-01)

In vivo imaging of MMP‐13 activity using a specific polymer‐FRET peptide conjugate detects early osteoarthritis and inhibitor efficacy
per: Duro‐Castano, A, et al.
Publicat: (2018)

Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors
per: Haixiang Yu, et al.
Publicat: (2024-05-01)

Collagenases MMP-1, MMP-13, and Tissue Inhibitors TIMP-1, TIMP-2: Their Role in Healthy and Complicated Pregnancy and Potential as Preeclampsia Biomarkers—A Brief Review
per: Asparuh Nikolov, et al.
Publicat: (2020-10-01)

Author Correction: Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands
per: Edmond M. Linossi, et al.
Publicat: (2023-12-01)

In vitro and in vivo Expression of InterstitialCollagenase/MMP-1 by Human Mast Cells
per: Nick Di Girolamo, et al.
Publicat: (2000-01-01)

Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
per: Chiranjeevi Padala, et al.
Publicat: (2017-01-01)

An ADAM10 Exosite Inhibitor Is Efficacious in an In Vivo Collagen-Induced Arthritis Model
per: Juan Diez, et al.
Publicat: (2024-01-01)

Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10
per: Dmitriy Minond, et al.
Publicat: (2020-05-01)

MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1
per: Yamamoto, K, et al.
Publicat: (2016)

Chain register shift in type I collagen alters MMP1 cleavage
per: Kuznetsova, N, et al.
Publicat: (2006)

The Catalytic Domain Mediates Homomultimerization of MT1-MMP and the Prodomain Interferes with MT1-MMP Oligomeric Complex Assembly
per: Marton Fogarasi, et al.
Publicat: (2022-08-01)

The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface.
per: Itoh, Y, et al.
Publicat: (2008)

Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate
per: Franck Madoux, et al.
Publicat: (2016-12-01)

Probing of exosites leads to novel inhibitor scaffolds of HCV NS3/4A proteinase.
per: Sergey A Shiryaev, et al.
Publicat: (2012-01-01)

Mass spectrometry defines the C-terminal dimerization domain and enables modeling of the structure of full-length OmpA
per: Marcoux, J, et al.
Publicat: (2014)

Mass spectrometry defines the C-terminal dimerization domain and enables modeling of the structure of full-length OmpA.
per: Marcoux, J, et al.
Publicat: (2014)

Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.
per: La Pietra, V, et al.
Publicat: (2012)